Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
EpiEndo Pharmaceuticals logo — EPIENDO PHARMACEUTICALS IS AN ICELANDIC COMPANY FOCUSED ON N...

EpiEndo Pharmaceuticals

EPIENDO PHARMACEUTICALS IS AN ICELANDIC COMPANY FOCUSED ON NOVEL SOLUTIONS FOR CHRONIC AIRWAY DISEASES

Founded 2014 Iceland Iceland 18 employees Series A Total: $43.62M Biotechnology, Health Care

General Information

Company Name EpiEndo Pharmaceuticals
Founded Year 2014
Location Iceland Iceland +1
Founders / Decision Makers
Team member
Employees 18
Industries Biotechnology, Health Care
Funding Stage Series A
Social

Get notified when EpiEndo Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About EpiEndo Pharmaceuticals

EpiEndo Pharmaceuticals is an Icelandic clinical stage pharmaceutical company founded in 2014. The company focuses on impairment of epithelial barriers as a common mechanism of many inflammatory conditions such as the airway, gastrointestinal tract, and skin. Their slogan, "EPIENDO PHARMACEUTICALS IS AN ICELANDIC COMPANY FOCUSED ON NOVEL SOLUTIONS FOR CHRONIC AIRWAY DISEASES," reflects their dedication to addressing chronic airway diseases through innovative solutions. EpiEndo Pharmaceuticals recently secured a noteworthy €20.00M Series A investment on 18 August 2021. The investment was led by prominent investors including, The European Innovation Council, Kvika Asset Management, ABC Ventures, and Flerie Invest. With its focus on biotechnology and health care, this Icelandic company is poised to make a significant impact in the pharmaceutical industry. The company's unique approach to addressing chronic airway diseases makes it a promising venture for investors seeking to support groundbreaking solutions in the health care sector. EpiEndo Pharmaceuticals' innovative focus and recent investment indicate the growing interest in their work and the potential for significant advancements in the treatment of chronic airway diseases.

Taxonomy: Pharmaceuticals, Clinical Stage, Icelandic Company, Epithelial Barriers, Inflammatory Conditions, Airway Diseases, Gastrointestinal Tract, Skin Diseases, Chronic Conditions, Start-up, Drug Development, Research and Development, Innovation

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 4
Investor
•••• •••• 		18 Aug 2021
Debt Financing •••••• 1
Investor
21 Apr 2021
Seed Round •••••• 3
Investor Investor
•••• •••• 		18 Dec 2019
Grant •••••• 1
Investor
18 Dec 2019
Angel Round •••••• 1
Investor
18 Jan 2019

View All 8 Funding Rounds

EpiEndo Pharmaceuticals Alternatives & Competitors

EpiEndo Pharmaceuticals vs
Hope Medicine
Hope Medicine

Dedicated to pioneering new treatments that enhance life quality for both men and women across a spe...

Series B
Health Care
EpiEndo Pharmaceuticals vs
PRAEVENTIX LLC
PRAEVENTIX LLC

Pioneering the future of healthcare by developing innovative therapies for bowel, dermatologic, auto...

Series Unknown
1 employees
Biotechnology, Health Care
EpiEndo Pharmaceuticals vs
KeyNeurotek Pharmaceuticals
KeyNeurotek Pharmaceuticals

Pioneering the next generation of small molecule therapies for neuronal and autoimmune conditions.

Series C
2 employees
Biotechnology, Health Care

FAQ About EpiEndo Pharmaceuticals

EPIENDO PHARMACEUTICALS IS AN ICELANDIC COMPANY FOCUSED ON NOVEL SOLUTIONS FOR CHRONIC AIRWAY DISEASES
EpiEndo Pharmaceuticals was founded in 2014.
EpiEndo Pharmaceuticals is headquartered in Iceland.
EpiEndo Pharmaceuticals operates in the following industries: Biotechnology, Health Care.
EpiEndo Pharmaceuticals has approximately 18 employees.
EpiEndo Pharmaceuticals has completed 8 funding rounds, raising a total of $43.62M. The latest funding stage is Series A.
Top alternatives and competitors to EpiEndo Pharmaceuticals include Hope Medicine, PRAEVENTIX LLC, KeyNeurotek Pharmaceuticals, AveXis, Delpor, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EpiEndo Pharmaceuticals and Hope Medicine are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors EpiEndo Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes